Higher coated-platelet levels are associated with stroke recurrence following nonlacunar brain infarction

被引:43
作者
Prodan, Calin I. [1 ,2 ]
Stoner, Julie A. [3 ]
Cowan, Linda D. [3 ]
Dale, George L. [4 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Neurol, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA
[3] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK 73104 USA
[4] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA
关键词
platelets; recurrence; stroke; thrombosis; ISCHEMIC-STROKE; EARLY RISK; LACUNAR; CLOPIDOGREL; PREVENTION; GUIDELINES; SEROTONIN; STATEMENT; CORONARY; SUBTYPE;
D O I
10.1038/jcbfm.2012.168
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coated-platelets are procoagulant platelets observed upon dual-agonist stimulation with collagen and thrombin. Coated-platelet levels are elevated in patients with nonlacunar (large-vessel) ischemic stroke and decreased in patients with spontaneous intracerebral hemorrhage as compared with controls. The purpose of this study was to investigate a possible relationship between coated-platelet levels and stroke recurrence in patients with nonlacunar ischemic stroke. We assayed coated-platelet levels in 190 consecutive patients with nonlacunar stroke who were followed for up to 12 months; 20 subjects experienced recurrent stroke. Subjects were categorized into tertiles of coated-platelet levels. The distributions of time-to-recurrent stroke were estimated for each tertile using cumulative incidence curves and compared statistically using a log-rank test. The cumulative incidence of recurrent stroke at 12 months differed among the coated-platelet tertiles: 2% for the first tertile (lowest coated-platelet levels), 18% for the second tertile, and 17% for the third tertile (overall log-rank test, P=0.019). These data suggest that higher levels of coated-platelets, measured shortly after a nonlacunar stroke, are associated with an increased incidence of stroke recurrence. This observation offers an additional tool for identifying patients at highest risk for stroke recurrence following a nonlacunar (large-vessel) infarct. Journal of Cerebral Blood Flow & Metabolism (2013) 33, 287-292; doi: 10.1038/jcbfm.2012.168; published online 14 November 2012
引用
收藏
页码:287 / 292
页数:6
相关论文
共 32 条
[1]   Guidelines for the Early Management of Patients With Ischemic Stroke - 2005 guidelines update - A scientific statement from the Stroke Council of the American Heart Association/American Stroke Association [J].
Adams, H ;
Adams, R ;
Del Zoppo, G ;
Goldstein, LB .
STROKE, 2005, 36 (04) :916-923
[2]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[3]   Surface expression and functional characterization of α-granule factor V in human platelets:: effects of ionophore A23187, thrombin, collagen, and convulxin [J].
Alberio, L ;
Safa, O ;
Clemetson, KJ ;
Esmon, CT ;
Dale, GL .
BLOOD, 2000, 95 (05) :1694-1702
[4]   Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events [J].
Bhatt, DL ;
Fox, KAA ;
Hacke, W ;
Berger, PB ;
Black, HR ;
Boden, WE ;
Cacoub, P ;
Cohen, EA ;
Creager, MA ;
Easton, JD ;
Flather, MD ;
Haffner, SM ;
Hamm, CW ;
Hankey, GJ ;
Johnston, SC ;
Mak, KH ;
Mas, JL ;
Montalescot, G ;
Pearson, TA ;
Steg, PG ;
Steinhubl, SR ;
Weber, MA ;
Brennan, DM ;
Fabry-Ribaudo, L ;
Booth, J ;
Topol, EJ ;
Frye, RL ;
Amarenco, P ;
Brass, LM ;
Buyse, M ;
Cohen, LS ;
DeMets, DL ;
Fuster, V ;
Hart, RG ;
Marler, JR ;
McCarthy, C ;
Schoemig, A ;
Lincoff, AM ;
Brener, SJ ;
Sila, CA ;
Albuquerque, A ;
Aroutiounov, G ;
Artemiev, D ;
Atkeson, BG ;
Bartel, T ;
Basart, DCG ;
Lima, AB ;
Belli, G ;
Bordalo e Sa, AL ;
Bosch, X .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) :1706-1717
[5]   Antiplatelet therapy in ischemic stroke: Variability in clinical trials and its impact on choosing the appropriate therapy [J].
Biller, Jose .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 284 (1-2) :1-9
[6]   Scott syndrome dogs have impaired coated-platelet formation and calcein-release but normal mitochondrial depolarization [J].
Brooks, M. B. ;
Catalfamo, J. L. ;
Friese, P. ;
Dale, G. L. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (09) :1972-1974
[7]   Underestimation of the early risk of recurrent stroke - Evidence of the need for a standard definition [J].
Coull, AJ ;
Rothwell, PM .
STROKE, 2004, 35 (08) :1925-1929
[8]   Coated-platelets: an emerging component of the procoagulant response [J].
Dale, GL .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (10) :2185-2192
[9]   Quantitation of microparticles released from coated-platelets [J].
Dale, GL ;
Remenyi, G ;
Friese, P .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (09) :2081-2088
[10]   Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface [J].
Dale, GL ;
Friese, P ;
Batar, P ;
Hamilton, SF ;
Reed, GL ;
Jackson, KW ;
Clemetson, KJ ;
Alberio, L .
NATURE, 2002, 415 (6868) :175-179